187 related articles for article (PubMed ID: 12775947)
1. Anti-atherosclerotic effects of statins: lessons from prevention trials.
Ganesh SK; Nass CM; Blumenthal RS
J Cardiovasc Risk; 2003 Jun; 10(3):155-9. PubMed ID: 12775947
[TBL] [Abstract][Full Text] [Related]
2. [Statins: possibly more than just lowering of the lipid level].
Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ
Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742
[TBL] [Abstract][Full Text] [Related]
3. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
De Caterina R; Lenzi S
G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
[TBL] [Abstract][Full Text] [Related]
5. [Statins have other beneficial properties besides their cholesterol lowering effect].
Eriksson M
Lakartidningen; 1998 Aug; 95(35):3670-2. PubMed ID: 9748780
[TBL] [Abstract][Full Text] [Related]
6. [The pleiotropic effects of statins].
Wolfovitz E
Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Köenig W
J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
[TBL] [Abstract][Full Text] [Related]
8. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
9. Statins and cardioprotection--more than just lipid lowering?
Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
[TBL] [Abstract][Full Text] [Related]
10. Synthetic statins: more data on newer lipid-lowering agents.
Wierzbicki AS
Curr Med Res Opin; 2001; 17(1):74-7. PubMed ID: 11464449
[TBL] [Abstract][Full Text] [Related]
11. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
12. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
Ray KK; Cannon CP; Ganz P
Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
[TBL] [Abstract][Full Text] [Related]
13. Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
Wierzbicki AS
Curr Med Res Opin; 2005 Feb; 21(2):299-306. PubMed ID: 15802001
[TBL] [Abstract][Full Text] [Related]
14. The role of statins in reversing atherosclerosis: what the latest regression studies show.
Grines CL
J Interv Cardiol; 2006 Feb; 19(1):3-9. PubMed ID: 16483333
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects and cholesterol-lowering therapy.
Shaw SM; Fildes JE; Yonan N; Williams SG
Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
[TBL] [Abstract][Full Text] [Related]
16. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
Nissen SE
Am J Cardiol; 2005 Sep; 96(5A):61F-68F. PubMed ID: 16126025
[TBL] [Abstract][Full Text] [Related]
17. Beyond the laboratory: clinical implications for statin pleiotropy.
Halcox JP; Deanfield JE
Circulation; 2004 Jun; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
[TBL] [Abstract][Full Text] [Related]
18. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
19. Statins and plaque stability.
Gomberg-Maitland M; Fuster V; Fayad ZA; Badimon JJ; Corti R
J Cardiovasc Risk; 2003 Jun; 10(3):161-7. PubMed ID: 12775948
[TBL] [Abstract][Full Text] [Related]
20. Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials.
Khush KK; Waters DD
J Card Fail; 2006 Oct; 12(8):664-74. PubMed ID: 17045188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
